Metabolic Syndromes as Important Comorbidities in Patients of Inherited Retinal Degenerations: Experiences from the Nationwide Health Database and a Large Hospital-Based Cohort
Open Access
- 20 February 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (4), 2065
- https://doi.org/10.3390/ijerph18042065
Abstract
This study aimed to evaluate the medical and socioeconomic impacts of IRDs using the nationwide health database and a large hospital-based cohort. This retrospective cross-sectional cohort study used data from the nationwide National Health Insurance Research Database (NHIRD). All patients with IRD from January 2012 to December 2016 were selected from the NHIRD and matched with the general population at a ratio of 1:4. All variables, including comorbidities, medications, service utilization, and medical costs, within 1 year from the date of the IRD diagnosis, were analyzed. Disability data were retrieved from the Taiwan Inherited retinal degeneration Project (TIP), a medical center-based database. A total of 4447 and 17,788 subjects from the nationwide database were included in the IRD and control groups, respectively. The Charlson comorbidity index score was higher in the IRD group (0.74:0.52, p < 0.001). Yearly visits to the ophthalmology clinic were more frequent in the IRD group (6.80:1.06, p < 0.001), particularly to tertiary medical centers (p < 0.001). The IRD group showed greater odds ratios (OR) for metabolic syndrome-related comorbidities, including hypertension (OR = 1.18, 95% confidence interval (CI) 1.10 to 1.26) and diabetes (OR = 1.32, 95% CI 1.21 to 1.45), and double the average yearly medical cost (2104.3 vs. 1084.6 USD, p < 0.001) and ten times the yearly ophthalmology cost (369.1 vs. 36.1 USD, p < 0.001). The average disability level was 54.17% for all subjects. This study revealed the large medical and socioeconomic impacts of IRD on not only patients with IRD, but also their family members and the whole society.Funding Information
- National Taiwan University Hospital (NTUH-104-002877, NTUH-106-003630, NTUH-108-N04)
This publication has 27 references indexed in Scilit:
- Mental Health of People with Retinitis PigmentosaOptometry and Vision Science, 2013
- Health Services Utilization and Cost of Retinitis PigmentosaAmerican Journal of Ophthalmology, 2012
- Comorbid Visual and Cognitive ImpairmentAsia Pacific Journal of Public Health, 2012
- Healthcare costs associated with progressive diabetic retinopathy among National Health Insurance enrollees in Taiwan, 2000-2004BMC Health Services Research, 2010
- Leber congenital amaurosis: Clinical correlations with genotypes, gene therapy trials update, and future directionsJournal of American Association for Pediatric Ophthalmology and Strabismus, 2009
- Prospects for retinal gene replacement therapyTrends in Genetics, 2009
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisThe New England Journal of Medicine, 2008
- Does Universal Health Insurance Make Health Care Unaffordable? Lessons From TaiwanHealth Affairs, 2003
- Update on the molecular genetics of retinitis pigmentosaOphthalmic Genetics, 2001
- Cone and cone-rod dystrophies.Journal of Medical Genetics, 1992